Journey of a monoclonal antibody through IND and BLA filings

28 June 2022 , Sponsored by NanoTemper
Posted in Intelligence | Tagged ,

In this infographic by NanoTemper, follow the steps a monoclonal antibody takes on its journey when filing for both an investigational new drug (IND) and biologics license application (BLA).

In the infographic, learn about:

• The typical timeline and steps for the approval of a monoclonal antibody as a drug

• The definitions and objectives of both IND and BLA processes

• The importance of stability studies throughout the different phases of approval

Download the infographic

Related Articles

No related posts.

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free